Nothing Special   »   [go: up one dir, main page]

MX2007008723A - Polipeptidos de yersinia spp y metodos de uso. - Google Patents

Polipeptidos de yersinia spp y metodos de uso.

Info

Publication number
MX2007008723A
MX2007008723A MX2007008723A MX2007008723A MX2007008723A MX 2007008723 A MX2007008723 A MX 2007008723A MX 2007008723 A MX2007008723 A MX 2007008723A MX 2007008723 A MX2007008723 A MX 2007008723A MX 2007008723 A MX2007008723 A MX 2007008723A
Authority
MX
Mexico
Prior art keywords
polypeptides
methods
yersinia spp
yersinia
spp
Prior art date
Application number
MX2007008723A
Other languages
English (en)
Inventor
Daryll A Emery
Darren E Straub
Laura Wonderling
Original Assignee
Epitopix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitopix Llc filed Critical Epitopix Llc
Publication of MX2007008723A publication Critical patent/MX2007008723A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0291—Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invencion proporciona polipeptidos que se pueden aislar de una Yersinia spp. Tambien se proporcionan por la presente invencion composiciones que incluyen uno o mas de los polipeptidos, y a metodos de fabricacion y metodos de uso de los polipeptidos.
MX2007008723A 2005-01-21 2006-01-20 Polipeptidos de yersinia spp y metodos de uso. MX2007008723A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64610605P 2005-01-21 2005-01-21
PCT/US2006/002474 WO2006079076A2 (en) 2005-01-21 2006-01-20 Yersinia spp. polypeptides and methods of use

Publications (1)

Publication Number Publication Date
MX2007008723A true MX2007008723A (es) 2007-09-12

Family

ID=36649588

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007008723A MX2007008723A (es) 2005-01-21 2006-01-20 Polipeptidos de yersinia spp y metodos de uso.

Country Status (12)

Country Link
US (8) US8563004B2 (es)
EP (3) EP2431382A1 (es)
JP (3) JP2008528512A (es)
CN (1) CN101142230A (es)
AU (1) AU2006206234B2 (es)
BR (1) BRPI0606506A2 (es)
CA (1) CA2595163A1 (es)
DK (1) DK1848732T3 (es)
ES (1) ES2588010T3 (es)
MX (1) MX2007008723A (es)
NZ (1) NZ556651A (es)
WO (1) WO2006079076A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2279511T3 (es) * 1994-02-09 2007-08-16 Epitopix Llc Inmunizacion activa utilizando una proteina receptor de sideroforo.
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
CA2433561C (en) 2001-01-03 2014-04-01 Willmar Poultry Company, Inc. Compositions including gram negative siderophore receptor proteins and methods of use
US8329192B2 (en) 2003-09-19 2012-12-11 Epitopix Llc Campylobacter polypeptides and methods of use
EP2431382A1 (en) 2005-01-21 2012-03-21 Epitopix, LLC Yersinia SPP, polypeptides and methods of use
AU2012264385B2 (en) * 2011-05-31 2018-06-28 Hutchison Biofilm Medical Solutions Limited Dispersion and detachment of cell aggregates
US9631221B1 (en) 2011-09-02 2017-04-25 Becton, Dickinson And Company Identification of microorganisms using MALDI-TOF-MS on-plate extraction
EP2799542A4 (en) * 2011-12-29 2015-07-01 Tao Health Life Pharma Co Ltd A TARGET MOLECULE WITH AMYLOSPHEROID BINDING FOR INDUCING NEURONAL CELL DEOD, METHOD AND MEANS FOR INHIBITING AMYLOSPHEROID-INDUCED NEURONAL CELL DEOD AND APPLICATIONS THEREOF AND METHOD AND METHOD THEREFOR
EP2816110B1 (en) * 2012-02-13 2018-11-28 National University Corporation Kyoto Institute of Technology Peptide having affinity for silicon nitride (si3n4), and use therefor
US8753643B1 (en) 2012-04-11 2014-06-17 Life-Science Innovations, Llc Spray dried compositions and methods of use
US9017953B2 (en) * 2012-05-18 2015-04-28 Washington University Biomarker and therapeutic for urinary tract infection
RU2549712C1 (ru) * 2013-11-26 2015-04-27 Федеральное казенное учреждение здравоохранения "Ростовский-на-Дону ордена Трудового Красного Знамени научно-исследовательский противочумный институт" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека CПОСОБ ВЫДЕЛЕНИЯ ИНГИБИТОРА СЕКРЕЦИИ СИДЕРОФОРОВ, СИНТЕЗИРУЕМОГО pgm- ШТАММАМИ Y. pestis И ВЫДЕЛЕННЫЙ ИНГИБИТОР
FR3024903A1 (fr) * 2014-08-14 2016-02-19 Biomerieux Sa Procede de quantification d'au moins un groupe de microorganismes par spectrometrie de masse
WO2016058007A2 (en) * 2014-10-10 2016-04-14 Rare Element Resources, Ltd. Processing for the extraction of rare earth elements
AU2016209324B2 (en) 2015-01-20 2020-02-27 Igm Biosciences, Inc. Tumor necrosis factor (TNF) superfamily receptor binding molecules and uses thereof
WO2017083367A1 (en) 2015-11-09 2017-05-18 Epitopix, Llc Polypeptides of fusobacterium and methods of use
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
US10967056B2 (en) 2017-02-10 2021-04-06 Epitopix, Llc Proteins and immunizing compositions containing pasteurella proteins and methods of use
CN113613677A (zh) * 2019-10-18 2021-11-05 犹他大学研究基金会 聚合物药物递送缀合物及其制备方法和使用方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420253A (en) 1993-09-09 1995-05-30 Willmar Poultry Company, Inc. Method for purifying egg yolk immunoglobulins
US5830479A (en) 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
ES2279511T3 (es) 1994-02-09 2007-08-16 Epitopix Llc Inmunizacion activa utilizando una proteina receptor de sideroforo.
JPH09505085A (ja) * 1994-03-22 1997-05-20 ファイザー インク． パスツレラ科抗原および関連ワクチン
US5538733A (en) 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
AU5597998A (en) * 1996-12-04 1998-06-29 Heska Corporation Recombinant plague vaccine
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US20020061569A1 (en) 2000-03-21 2002-05-23 Robert Haselbeck Identification of essential genes in prokaryotes
CA2433561C (en) 2001-01-03 2014-04-01 Willmar Poultry Company, Inc. Compositions including gram negative siderophore receptor proteins and methods of use
AT410798B (de) 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
GB0127657D0 (en) * 2001-11-19 2002-01-09 Microscience Ltd Virulence genes and proteins and their use
CA2493977A1 (en) * 2002-08-02 2004-02-19 Glaxosmithkline Biologicals Sa Vaccine composition comprising lipooligosaccharide with reduced phase variability
US8329192B2 (en) 2003-09-19 2012-12-11 Epitopix Llc Campylobacter polypeptides and methods of use
CN101014618B (zh) 2004-07-23 2013-01-02 诺华疫苗和诊断有限公司 抗原的寡聚装配多肽
US9458204B2 (en) 2004-08-25 2016-10-04 Epitopix Llc Fusobacterium polypeptides and methods of use
EP2431382A1 (en) * 2005-01-21 2012-03-21 Epitopix, LLC Yersinia SPP, polypeptides and methods of use
CA2598488A1 (en) 2005-02-18 2006-08-31 Novartis Vaccines And Diagnostics, Inc. Immunogens from uropathogenic escherichia coli
US20120263724A1 (en) * 2005-04-20 2012-10-18 Manohar John Escherichia coli o157:h7 proteins and uses thereof

Also Published As

Publication number Publication date
EP2361926A3 (en) 2011-12-21
JP6224655B2 (ja) 2017-11-01
US9085613B2 (en) 2015-07-21
US20140161834A1 (en) 2014-06-12
ES2588010T3 (es) 2016-10-28
EP2361926A2 (en) 2011-08-31
US9109018B2 (en) 2015-08-18
US9352029B2 (en) 2016-05-31
CN101142230A (zh) 2008-03-12
JP2015193645A (ja) 2015-11-05
NZ556651A (en) 2010-05-28
CA2595163A1 (en) 2006-07-27
EP1848732B1 (en) 2016-07-27
US20160051655A1 (en) 2016-02-25
US9221899B2 (en) 2015-12-29
JP2013018779A (ja) 2013-01-31
US20060269564A1 (en) 2006-11-30
BRPI0606506A2 (pt) 2009-06-30
US20110206674A1 (en) 2011-08-25
AU2006206234B2 (en) 2012-01-12
WO2006079076A2 (en) 2006-07-27
DK1848732T3 (en) 2016-11-14
WO2006079076A3 (en) 2007-03-29
EP2431382A1 (en) 2012-03-21
US20140170164A1 (en) 2014-06-19
JP2008528512A (ja) 2008-07-31
US9801932B2 (en) 2017-10-31
US8563004B2 (en) 2013-10-22
US20140161838A1 (en) 2014-06-12
US20160228527A1 (en) 2016-08-11
US9085612B2 (en) 2015-07-21
US20150307598A1 (en) 2015-10-29
EP1848732A2 (en) 2007-10-31
JP6178059B2 (ja) 2017-08-09
AU2006206234A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
MX2007008723A (es) Polipeptidos de yersinia spp y metodos de uso.
HK1117746A1 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
TW200732349A (en) Anti-OX40L antibodies and methods using same
GB2453058A (en) Kinase antagonists
MX2010004374A (es) Armazones proteinicos.
MX2010006738A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
WO2008121767A3 (en) Stitched polypeptides
JO2778B1 (en) Certain vehicles, installations and methods
TN2009000239A1 (en) 4-phenyl-pyrane-3,5-diones,4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
MX341370B (es) Antagonistas anti - beta7 humanizados y usos para los mismos.
WO2008060705A3 (en) Anti-dll4 antibodies and methods using same
GB2430677A8 (en) Novel antigenbinding polypeptides and their uses
UA101346C2 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы как гербициды
TNSN07196A1 (en) Potentiators of glutamate receptors
WO2007130697A3 (en) Anti-ephb4 antibodies and methods using same
WO2008013589A3 (en) Treatment of ras-expressing tumors
TW200608973A (en) Rapamycin polymorph Ⅱ and uses thereof
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
WO2009042114A3 (en) Phenazine derivatives and uses thereof
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
TN2010000045A1 (en) Novel herbicides
MY163037A (en) Endoparasiticidal compositions
WO2005087793A3 (en) Immunostimulatory compositions and uses thereof
WO2006127368A3 (en) Methods for synthesizing imidazotriazinones
TW200638932A (en) CCI-779 polymorph and use thereof

Legal Events

Date Code Title Description
FG Grant or registration